AC Immune S.A. ( ACIU) - Stock Earnings
ACIU Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 3, 2026, midnight | — / — | — | — / — | — |
ACIU Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -18.1 million USD | 426009 USD |
| 2026Q1 | -18.5 million USD | 1.4 million USD |
| 2026Q2 | 2.3 million USD | 18.7 million USD |
| 2026Q4 Est. | — | — |
ACIU Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -64.5 million USD | 17.6 million USD |
| 2024 | -56.3 million USD | 30.2 million USD |
| 2025 | -88.8 million USD | 4.5 million USD |
| 2026 Est. | — | — |
ACIU
Price: $2.45
52 week price:
Earnings Per Share: -0.53 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: Switzerland
Volume: 182100
Ebitda: -8.8 millionMarket Capitalization: 272.2 million